These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25736187)

  • 1. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
    J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M; Schaffer A; Barbieri L; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
    Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
    Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Bellomo G; Marino P; Sinigaglia F; De Luca G
    J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M; Ceccon C; Nardin M; Suryapranata H; De Luca G;
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
    Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
    J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
    Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
    Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
    Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
    J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.